Quick facts
- Also called: a classified board
- Statutory basis: 8 Del. C. § 141(d)
- Structure: directors split into one, two or three classes
- Effect: only one class is elected each year
- Consequence: gaining board control takes two annual meetings, not one
A staggered board, also called a classified board, divides directors into classes with terms that expire in different years. Only one class stands for election at each annual meeting. Someone who wants to control the board cannot replace it in a single vote, no matter how many shares they own.
In plain English
Ordinarily every director is up for election every year, so whoever wins the vote controls the board immediately. A staggered board removes that possibility. Win every seat available and you still hold only a third of the board. You have to come back and win again the following year.
That extra year is the entire point.
What the statute actually says
Delaware permits it directly. Directors "may, by the certificate of incorporation or by an initial bylaw, or by a bylaw adopted by a vote of the stockholders, be divided into 1, 2 or 3 classes," with the first class expiring at the first annual meeting after classification, the second a year later, and the third a year after that.1
Three classes is the version that matters, because it produces the two-year delay.
The provision that does the real work
Classification alone would be weaker if shareholders could simply remove directors mid-term. Delaware closes that door. Directors can normally be removed with or without cause by a majority vote, except that "unless the certificate of incorporation otherwise provides, in the case of a corporation whose board is classified... stockholders may effect such removal only for cause."1
So on a classified board, an unhappy majority cannot simply vote directors out between meetings. They must show cause, which means a real reason, not a disagreement about strategy. Classification plus the removal restriction is what converts a governance preference into a defence.
Why it pairs with a poison pill
A poison pill stops a bidder from buying control on the open market. A staggered board stops them from voting it. Neither is decisive alone. Together they force a bidder to win two consecutive proxy contests while the pill stays in place throughout, because the only people who can redeem the pill are the directors the bidder has not yet been able to replace.
This is why the two are discussed together, and why removing one substantially weakens the other.
Where this was tested
Air Products & Chemicals, Inc. v. Airgas, Inc. is the case, decided by the Delaware Court of Chancery in February 2011. Airgas had a "staggered board of directors, divided into three equal classes with one class (three directors) up for election each year."2
Air Products pursued Airgas for more than a year, raised its offer repeatedly, and won a proxy contest to seat its own nominees in one class. It still did not control the board. The court framed the question the case posed as whether a board may "just say no" to a hostile tender offer, when it may do so, and ultimately whether a board can "just say never."2
The court observed that the structure, "combined with a staggered board," had given the Airgas board over a full year to inform its stockholders of its own view of the company's intrinsic value.2
The defence held. Note the court, though: this was the Court of Chancery, not the Delaware Supreme Court, and it is frequently misattributed.
The limits
A staggered board is not permanent immunity. The pill that pairs with it is still subject to review of how the directors actually use it. The Delaware Supreme Court was explicit in Moran that approving the adoption of a rights plan settles nothing about later conduct: "the ultimate response to an actual takeover bid must be judged by the Directors' actions at that time."3
Delay is defensible when directors are using it to get a better outcome for shareholders. It is harder to defend when the delay is the outcome.
The case for and against
For. Directors can plan past the next annual meeting. Institutional knowledge survives a bad year. A bidder has to negotiate rather than accumulate, which tends to raise the price.
Against. It insulates directors from the people who elected them. Poor performance takes two years to correct instead of one. Shareholders who want change have a slower route to it, and the structure protects weak management exactly as effectively as it protects good management.
The honest summary is that the structure does not distinguish between the two. It buys time, and what the time is worth depends entirely on who is using it.
What this means if you are private
You almost certainly do not have a classified board, and you do not need one. The transferable point is about timing rules rather than vote counting. Your protective provisions, board composition terms, and removal mechanics decide how quickly control can change hands, and they are negotiated long before anyone wants to change it.
Ask a specific question about your own documents: if your investors decided tomorrow that you should not run the company, how many steps and how long would that take? The answer is your version of this page.
What to do next
Read the hostile takeover guide for how board structure interacts with the other defences during a live bid.
Related reading
- Proxy Fight covers the mechanism a staggered board slows
- Poison Pill covers the defence it pairs with
- Cumulative Voting covers a rule that cuts the other way, helping minority holders win seats
- Majority Voting covers the threshold directors must clear to be elected at all